Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
Minimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic factors and treatment effects on survival--a retrospective study of 42 adult cases. [electronic resource] by
- Gougounon, Alice
- Abahssain, Halima
- Rigollet, Lauren
- Elhamri, Mohamed
- Tigaud, Isabelle
- Chelghoum, Youcef
- Plesa, Adriana
- Dumontet, Charles
- Michallet, Mauricette
- Thomas, Xavier
Producer: 20110929
In:
Leukemia research vol. 35
Availability: No items available.
|
|
|
16.
|
Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making? [electronic resource] by
- Thomas, Xavier
- Chelghoum, Youcef
- Cannas, Giovanna
- Elhamri, Mohamed
- Labussière, Hélène
- Tigaud, Isabelle
- Ducastelle, Sophie
- Nicolini, Franck
- Dumontet, Charles
- Michallet, Mauricette
Producer: 20111214
In:
Clinical lymphoma, myeloma & leukemia vol. 11
Availability: No items available.
|
|
|
17.
|
Higher percentage of CD34 + CD38- cells detected by multiparameter flow cytometry from leukapheresis products predicts unsustained complete remission in acute myeloid leukemia. [electronic resource] by
- Plesa, Adriana
- Elhamri, Mohamed
- Clapisson, Gilles
- Mattei, Eve
- Gazzo, Sophie
- Hequet, Olivier
- Tigaud, Isabelle
- Michallet, Mauricette
- Dumontet, Charles
- Thomas, Xavier
Producer: 20160322
In:
Leukemia & lymphoma vol. 56
Availability: No items available.
|
|
|
18.
|
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance. [electronic resource] by
- Roche-Lestienne, Catherine
- Deluche, Lauréline
- Corm, Sélim
- Tigaud, Isabelle
- Joha, Sami
- Philippe, Nathalie
- Geffroy, Sandrine
- Laï, Jean-Luc
- Nicolini, Franck-Emmanuel
- Preudhomme, Claude
Producer: 20080515
In:
Blood vol. 111
Availability: No items available.
|
|
|
19.
|
Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line. [electronic resource] by
- Dulucq, Stephanie
- Etienne, Gabriel
- Morisset, Stephane
- Klein, Emilie
- Chollet, Claudine
- Robbesyn, Fanny
- Turcq, Beatrice
- Tigaud, Isabelle
- Hayette, Sandrine
- Nicolini, Franck E
- Mahon, François-Xavier
Producer: 20190425
In:
Annals of hematology vol. 98
Availability: No items available.
|
|
|
20.
|
Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended. [electronic resource] by
- Huet, Sarah
- Cony-Makhoul, Pascale
- Heiblig, Maël
- Tigaud, Isabelle
- Gazzo, Sophie
- Belhabri, Amine
- Souche, Denis
- Michallet, Mauricette
- Magaud, Jean-Pierre
- Hayette, Sandrine
- Nicolini, Franck
Producer: 20150518
In:
PloS one vol. 9
Availability: No items available.
|